Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rongsu Qi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|August 7, 2012
Proteolytic processing regulates Toll-like receptor 3 stability and endosomal localizationRongsu Qi, Divyendu Singh, C Cheng Kao
The Journal of Biological Chemistry|February 7, 2013
The human antimicrobial peptide LL-37, but not the mouse ortholog, mCRAMP, can stimulate signaling by poly(I:C) through a FPRL1-dependent pathwayDivyendu Singh, Rongsu Qi, Jarrat L Jordan, et al.
Cancer Immunology Research|February 24, 2022
Molecular Signature of Tumor-Associated High Endothelial Venules That Can Predict Breast Cancer SurvivalJunko Sawada, Nobuyoshi Hiraoka, Rongsu Qi, et al.
The Journal of Biological Chemistry|September 22, 2010
Secretion of the human Toll-like receptor 3 ectodomain is affected by single nucleotide polymorphisms and regulated by Unc93b1Rongsu Qi, Scott Hoose, Jessica Schreiter, et al.
International Journal of Molecular Sciences|August 14, 2025
Feasibility of Manufacturing and Antitumor Activity of TIL for Advanced Endometrial CancersYongliang Zhang, Kathleen N Moore, Amir A Jazaeri, et al.
Cancer Discovery|April 2, 2024
Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint InhibitorsAdam J Schoenfeld, Sylvia M Lee, Bernard Doger de Spéville, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Lymphotoxin-driven cancer cell eradication by tumoricidal CD8<sup>+</sup> TILHongyan Xie, Aiping Jiang, Aonkon Dey, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|August 7, 2012
Proteolytic processing regulates Toll-like receptor 3 stability and endosomal localizationRongsu Qi, Divyendu Singh, C Cheng Kao
The Journal of Biological Chemistry|February 7, 2013
The human antimicrobial peptide LL-37, but not the mouse ortholog, mCRAMP, can stimulate signaling by poly(I:C) through a FPRL1-dependent pathwayDivyendu Singh, Rongsu Qi, Jarrat L Jordan, et al.
Cancer Immunology Research|February 24, 2022
Molecular Signature of Tumor-Associated High Endothelial Venules That Can Predict Breast Cancer SurvivalJunko Sawada, Nobuyoshi Hiraoka, Rongsu Qi, et al.
The Journal of Biological Chemistry|September 22, 2010
Secretion of the human Toll-like receptor 3 ectodomain is affected by single nucleotide polymorphisms and regulated by Unc93b1Rongsu Qi, Scott Hoose, Jessica Schreiter, et al.
International Journal of Molecular Sciences|August 14, 2025
Feasibility of Manufacturing and Antitumor Activity of TIL for Advanced Endometrial CancersYongliang Zhang, Kathleen N Moore, Amir A Jazaeri, et al.
Cancer Discovery|April 2, 2024
Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint InhibitorsAdam J Schoenfeld, Sylvia M Lee, Bernard Doger de Spéville, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Lymphotoxin-driven cancer cell eradication by tumoricidal CD8<sup>+</sup> TILHongyan Xie, Aiping Jiang, Aonkon Dey, et al.
Pageof 1